Alembic Pharma gets USFDA nod for Paliperidone extended-release Tablets 0 27.09.2024 11:10 Business Standard Alembic Pharmaceuticals has announced that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Paliperidone extended-release tablets. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
